August 12, 2016
Tel Aviv, Israel-based BioLineRx Ltd. announced that Philip A. Serlin has been named Chief Executive Officer, effective October 10, 2016. Mr. Serlin joined the company in 2009 as Chief Financial and Operating Officer. He succeeds Kinneret Savitsky, Ph.D., who has served as CEO since 2010. Dr. Savitsky will serve as scientific advisor to the Company through the end of March 2017.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.